Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, today announced an option, research and license agreement worth up to...
Continue Reading
Enzene Biosciences, a subsidiary of Alkem Laboratories, has formally opened its first fully connected continuous Biologics manufacturing facility in Pune. This first-of-its-kind facility was built...
Continue Reading
The government has given approval for setting up four medical device parks with a view to support Make in India initiative and provide world-class products...
Continue Reading
India’s drug regulator has approved (India)’s new anti-tuberculosis drug rifapentine , waiving local clinical trials in a move to bolster efforts to prevent latent infections...
Continue Reading
In an endeavour recognizing the need to provide solutions to post-operative cataract patients to enhance vision, Johnson & Johnson Vision, a global leader in eye...
Continue Reading
the United States and European Union finalized a Mutual Recognition Agreement (MRA) for drug manufacturing inspections. Both parties have now fully implemented the MRA for...
Continue Reading
For being born as Human being all through my professional years, I relished the journey of my life from where I was once to be...
Continue Reading
At GSK, we work on vaccines aiming to help combat devastating infectious diseases like malaria, tuberculosis, HSV, RSV and COPD. Jeff Ulmer, Head Preclinical R&D...
Continue Reading
Five years ago, Biocon’s biologics business largely consisted of insulin clones and was worth about ₹400 crore. At the time, Biocon was valued at just...
Continue Reading